Found 12 matching trials
Sarcosine Preventive Therapy for Individuals At High Risk for Schizophrenia PHASE2 The purpose of this study is to determine whether preventative treatment wi...
Show More Location
Ezrath Nashim - Herzog Memorial Hospital
Learn More & Join Trial
Sarcosine (N-Methylglycine) Monotherapy for Schizophrenia PHASE2 The etiology of schizophrenia remains unclear. Schizophrenia patients revea...
Show More Location
Department of Psychiatry, China Medical University Hospital
Learn More & Join Trial
The Impact of Pharmacological and Electric Modulation of NMDA Pathway on the Cognitive Flexibility and Volitional Movement Preparation in Patients With Parkinson's Disease NA The project will investigate the effect of pharmacological and electric mod...
Show More Location
China Medical University Hospital/Neuro Depart.
Learn More & Join Trial
Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT EARLY_PHASE1 This is an investigator-initiated, double-blind crossover study on the mech...
Show More Learn More & Join Trial
Carbon-11 Labeled Sarcosine in Prostate Cancer N/A Men with and without prostate cancer will have a PET/CT scan that measures ...
Show More Location
University of Michigan Health Systems
Learn More & Join Trial
Sarcosine or D-Serine Add-on Treatment for Chronic Schizophrenia PHASE2 Both GlyT-1 inhibitors and NMDA-glycine site agonists have been demonstrate...
Show More Location
China Medical University Hospital
Learn More & Join Trial
Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in Schizophrenia PHASE2 The purpose of study is to determine whether dietary supplement sarcosine i...
Show More Location
Central Clinical Hospital
Learn More & Join Trial
A Study of the Effects of Sarcosine on Symptoms and Brain Glycine Levels in People With Schizophrenia NA The NMDA receptor has been identified as having a role in substance use dis...
Show More Location
McLean Hospital, Brain Imaging Center
Learn More & Join Trial
N-methylglycine (Sarcosine) Treatment for Depression PHASE2 Major depressive disorder is a complex disease and most currently available...
Show More Location
Department of Psychiatry, China Medical University Hospital
Learn More & Join Trial
Evaluation of Efficacy and Safety of add-on Sarcosine in Patients With Major Depressive Disorder PHASE4 One-third of the patients with major depressive disorder do not respond to ...
Show More Learn More & Join Trial